Literature DB >> 18538589

Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.

Mohammad Javad Mokhtari1, Nasrin Motamed, Mohammad Ali Shokrgozar.   

Abstract

Prostate cancer (PCA) is the most common cancer diagnosed in men and the second most common cause of death due to cancers after lung cancer. Metastasis of cancer cells involves multiple processes and various cytophysiological changes, including changed adhesion capability between cells and extracellular matrix (ECM) and damaged intercellular interaction. Silibinin, a naturally occurring flavonoid antioxidant found in the milk thistle, has recently been shown to have potent antiproliferative effect against various malignant cell lines. In the present study, PC-3 cells were incubated with various concentrations of silibinin for different times; then, cell cytotoxicity, cell adhesion and cell motility were assessed using MTT assay, cell-matrix adhesion assay and cell migration assay, respectively. The results showed that silibinin exerted a dose- and time-dependent inhibitory effect on the viability, motility and adhesion of highly metastatic PC-3 cells. These observations indicate that silibinin can probably inhibit metastasis in PCA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538589     DOI: 10.1016/j.cellbi.2008.03.019

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  28 in total

Review 1.  Silybin and the liver: from basic research to clinical practice.

Authors:  Carmela Loguercio; Davide Festi
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 2.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

3.  Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.

Authors:  Mohadeseh Dastpeyman; Nasrin Motamed; Kayhan Azadmanesh; Ehsan Mostafavi; Vahid Kia; Ali Jahanian-Najafabadi; Mohammad Ali Shokrgozar
Journal:  Med Oncol       Date:  2011-11-19       Impact factor: 3.064

Review 4.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

5.  Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.

Authors:  Zohreh Jahanafrooz; Nasrin Motamed; Behnaz Bakhshandeh
Journal:  Cytotechnology       Date:  2017-03-20       Impact factor: 2.058

6.  Silibinin suppresses CD44 expression in prostate cancer cells.

Authors:  Alina M Handorean; Kui Yang; Eric W Robbins; Thomas W Flaig; Kenneth A Iczkowski
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

Review 7.  Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

8.  Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.

Authors:  I E Leon; V Porro; A L Di Virgilio; L G Naso; P A M Williams; M Bollati-Fogolín; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2014-01       Impact factor: 3.358

9.  Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.

Authors:  Kai-jie Wu; Jin Zeng; Guo-dong Zhu; Lin-lin Zhang; Dong Zhang; Lei Li; Jin-hai Fan; Xin-yang Wang; Da-lin He
Journal:  Acta Pharmacol Sin       Date:  2009-07-06       Impact factor: 6.150

10.  Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.

Authors:  Gagan Deep; Rahul Kumar; Anil K Jain; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-10       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.